1
Q
sumatriptan brand name
A
Imitrex
2
Q
Imitrex generic name
A
sumatriptan
3
Q
sumatriptan category
A
pain
4
Q
sumatriptan DEA
A
No
5
Q
sumatriptan therapeutic class
A
Anti-migraine Serotonin receptor agonist
6
Q
sumatriptan dosage forms
A
- oral tablet
- nasal solution
- transdermal patch
- injectable
7
Q
sumatriptan common indications
A
- migrane
- cluster headaches
8
Q
sumatriptan efficacy monitoring parameters
A
resolution of clinical signs of migraine headache
9
Q
sumatriptan MOA
A
binds with high affinity to serotonin (5-HT) receptors. Serotonin receptor agonists are believed to be effective in migraine either through vasoconstriction or through activation of 5-HT receptors on sensory nerve endings in the trigeminal system resulting in the inhibition of inflammation.
10
Q
sumatriptan patient consultation
A
avoid activities mental alertness or coordination until drug effects are known, as this drug may cause dizziness or somnolence
11
Q
rizatriptan brand name
A
Maxalt
12
Q
Maxalt generic name
A
rizatriptan
13
Q
rizatriptan therapeutic class
A
Anti-migraine Serotonin receptor agonist
14
Q
rizatriptan dosage forms
A
- oral tablet
- disintegrating tablet
15
Q
rizatriptan common indications
A
migraine
16
Q
rizatriptan efficacy monitoring parameters
A
resolution of clinical signs of migraine headache
17
Q
rizatriptan MOA
A
binds with high affinity to serotonin (5-HT) receptors. Serotonin receptor agonists are believed to be effective in migraine either through vasoconstriction or through activation of 5-HT receptors on sensory nerve endings in the trigeminal system resulting in the inhibition of inflammation.
18
Q
rizatriptan patient consultation
A
- allow disintegrating tablet to dissolve on tongue and then swallow, do not chew
- caution with driving and other tasks requiring alertness
- avoid alcohol and other CNS depressants
19
Q
rizatriptan category
A
pain
20
Q
rizatriptan DEA
A
No
21
Q
codeine brand name
A
- Tylenol with codeine
- Tylenol #3
22
Q
codeine category
A
pain
23
Q
codeine DEA
A
- C-II, C-III, C-IV, C-V in SD
- depending on amount
24
Q
codeine therapeutic class
A
opioid analgesic
25
codeine dosage forms
- oral tablet: codeine alone
- oral tablet: with acetaminophen
- oral elixir solution: with acetaminophen
26
codeine common indications
- acute pain
- cough
27
codeine efficacy monitoring parameters
decreased pain
28
codeine MOA
codeine is an opioid with very low affinity for opioid receptors. Its analgesic activity appears to result from conversion to morphine
29
codeine patient consultation
- use a laxative to prevent constipation
- may cause drowsiness, avoid driving and other tasks requiring motor coordination
- avoid alcohol and other CNS depressants
30
fentanyl brand name
Duragesic
31
Duragesic generic name
fentanyl (transdermal)
32
fentanyl category
pain
33
fentanyl DEA
C-II
34
fentanyl therapeutic class
opioid analgesic
35
fentanyl dosage forms
transdermal patch
36
fentanyl common indications
chronic pain: moderate to severe
37
fentanyl efficacy monitoring parameters
decreased pain
38
fentanyl MOA
fentanyl is an opioid agonist with predominant effects on the mu opioid receptor and is about 50-100x more potent as an analgesic than morphine
39
fentanyl patient consultation
- use a laxative for preventing constipation
- may cause drowsiness, avoid driving or other tasks requiring motor coordination
- avoid alcohol and other CNS depressants
- apply to clean, dry skin
- skin breaks may increase absorption
- remove old patch before applying new patch to skin
- febrile patients may have increased absorption
40
hydrocodone with acetaminophen brand name
- Vicodin
- Norco
- Lortab
- Lorcet
41
Vicodin, Norco, Lortab, Lorcet generic name
hydrocodone with acetaminophen
42
hydrocodone category
pain
43
hydrocodone DEA
C-II
44
hydrocodone therapeutic class
opioid analgesic
45
hydrocodone dosage forms
- oral tablet
- oral elixir / solution
- oral tablet: ER-24 hr abuse-deterrent
- oral capsule: ER-12 hr abuse-deterrent
46
hydrocodone common indications
severe pain
47
hydrocodone efficacy monitoring parameters
decreased pain
48
hydrocodone MOA
an opioid analgesic and antitussive with unknown MOA. Is thought to be related to the presence of opiate receptors in the CNS
49
hydrocodone patient consultation
- use a laxative to prevent constipation
- may cause drowsiness, avoid driving and other tasks requiring motor coordination
- avoid alcohol and other CNS depressants
50
morphine sulfate: ER brand name
MS Contin, Kadian
51
MS Contin, Kadian generic name
morphine sulfate: ER
52
morphine sulfate category
pain
53
morphine sulfate DEA
C-II
54
morphine sulfate therapeutic class
opioid analgesic
55
morphine sulfate dosage forms
- oral tablet
- oral tablet: ER
- oral tablet: ER, abuse-deterrent
- oral capsule: ER-24 hr
- oral solution
- rectal suppository
- injectable
56
morphine sulfate common indications
chronic pain: moderate to severe
57
morphine sulfate efficacy monitoring parameters
decreased pain
58
morphine sulfate MOA
morphine is a pure mu agonist. Mu receptors are responsible for analgesia, respiratory depression, miosis, decreased GI motility and euphoria
59
morphine sulfate patient consultation
- use a laxative to prevent constipation
- may cause drowsiness, avoid driving or other tasks requiring motor coordination
- avoid alcohol an other CNS depressants
- ER products must not be crushed or chewed, this will release the total dose of morphine all at once and increase risk of respiratory depression
- ER capsules can be opened and sprinkled on soft food but must be swallowed whole and not chewed
60
oxycodone, oxycodone + acetaminophen brand name
- OxyContin, Roxicodone
+ ace: Percocet, Roxicet, Endocet
61
- OxyContin, Roxicodone
+ ace: Percocet, Roxicet, Endocet
generic name
- oxycodone
- oxycodone + acetaminophen
62
oxycodone category
pain
63
oxycodone DEA
C-II
64
oxycodone terapeutic class
opioid analgesic
65
oxycodone dosage forms
- oral tablet
- oral capsule
- oral tablet: ER-12 hr abuse-deterrent
- oral capsule: 12 hr abuse-deterrent
- oral solution / concentrate
66
oxycodone common indications
chronic pain: moderate to severe
67
oxycodone efficacy monitoring parameters
decreased pain
68
oxycodone MOA
oxycodone is a pure mu agonist. Mu receptors are responsible for analgesia, respiratory depression, miosis, decreased GI motility and euphoria
69
oxycodone patient consultation
- use a laxative to avoid constipation
- may cause drowsiness, avoid driving and other tasks requiring motor coordination
- avoid alcohol and other CNS depressants
70
tramadol brand name
Ultram
71
Ultram generic name
tramadol
72
tramadol category
pain
73
tramadol DEA
C-IV
74
tramadol therapeutic class
opioid analgesic
75
tramadol dosage froms
- oral tablet
- oral tablet: ER
- oral capsule: ER-24 hr
- oral solution
76
tramadol common indications
chronic pain: moderate to moderately severe
77
tramadol efficacy monitoring parameters
decreased pain
78
tramadol MOA
a mu agonist and a weak inhibitor of serotonin and NE re-uptake. Mu receptors are responsible for analgesia, respiratory depression, miosis, decreased GI motility, and euphoria
79
tramadol patient consultation
- use a laxative to prevent constipation
- may cause drowsiness, avoid driving or other tasks requiring motor coordination
- ER products must not be crushed or chewed, but may be taken with or without food, and always the same way to avoid variability in absorption
80
Suboxone generic name
buprenorphine with naloxone
81
buprenorphine with naloxone brand name
Suboxone
82
buprenorphine category
pain
83
buprenorphine DEA
C-III
84
buprenorphine therapeutic class
opioid partial agonist and antagonist combination
85
buprenorphine dosage forms
- sublingual film
- sublingual tablet
- buccal film
86
buprenorphine common indications
opioid use disorder
87
buprenorphine efficacy monitoring parameters
- urine drug screening tests that are negative for illicit drugs.
- Relief of signs and symptoms associated with narcotic addiction
88
buprenorphine with naboxone MOA
buprenorphine is an opioid receptor partial agonist. Naloxone is an opioid receptor antagonist that caused opioid withdrawal when injected parenterally and is included in the formulation to reduce the risk of abuse
89
buprenorphine patient consultation
- use a laxative to prevent constipation
- may cause drowsiness, avoid driving and other tasks requiring motor coordination
- avoid alcohol and other CNS depressants
- do not crush or swallow the SL tablet
- place the tablet / film under the tongue until it is dissolved, do not chew or swallow
- if using buccal film, press and hold film to moistened cheek for 5 sec with finger. If you need additional film, place on other cheek. Do not use more than 2 films simultaneously
